Baptist Cancer Center research proves incidental lung nodule program effective in detecting cancer early
09 mars 2023 08h00 HE
|
Baptist Memorial Health Care
Memphis, TN, March 09, 2023 (GLOBE NEWSWIRE) -- Memphis-based Baptist Cancer Center published a JAMA Network Open article proving the effectiveness of incidental lung nodule, or tumor, programs in...
Tritium to Add 250+ Tennessee Jobs; Recognized for Safe and Sustainable Workplace at U.S. Factory
15 févr. 2023 08h00 HE
|
Tritium DCFC Limited
LEBANON, Tenn., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Tritium DCFC Limited (“Tritium” of the “Company”) (Nasdaq: DCFC), a global leader in direct current (“DC”) fast chargers for electric vehicles...
Big Bad Breakfast Opens South Pittsburg, Tennessee Location in the Lodge Cast Iron Foundry and Museum
07 févr. 2023 09h00 HE
|
Big Bad Breakfast
LOUISVILLE, Ky., Feb. 07, 2023 (GLOBE NEWSWIRE) -- James Beard award-winning chef, author and restaurateur John Currence announces the opening of the fifth Tennessee location of the acclaimed Big...
Company Distilling Announces Partnership with the Tennessee Theatre, Becomes Official Bourbon of the State Theatre of Tennessee
15 déc. 2022 15h15 HE
|
Company Distilling
Knoxville, Tennessee, Dec. 15, 2022 (GLOBE NEWSWIRE) -- For the 2023 and 2024 seasons, Company Distilling and the historic Tennessee Theatre will work towards a shared vision of celebrating...
Provectus Biopharmaceuticals Announces Decision to Not Undertake Reverse Split of Outstanding and Authorized Equities in 2022; Expects to Seek Same Stockholder Approval Again in 2023
12 déc. 2022 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company’s Board of Directors (Board) has decided to not undertake the reverse stock split and...
Provectus Biopharmaceuticals Announces New Data from Combination Therapy Trial of Small Molecule Cancer Immunotherapy PV-10® and Keytruda® for First-Line Stage III Melanoma at Melanoma Bridge 2022
01 déc. 2022 07h00 HE
|
Provectus Biopharmaceuticals Inc.
50% CR and 83% ORR by RECIST 1.1 criteriaRapid CRs achieved within 15 to 27 weeksMedian PFS not reached during 2-year treatment interval; 83% PFS rate100% OS rate for CRs; ongoing after 18 to 36...
Company Distilling Announces Exploratory Product Line with Initial Premium Spirit Offering: Rye Single Barrel Finished with Cherry Wood
29 nov. 2022 09h32 HE
|
Company Distilling
Townsend, Tennessee, Nov. 29, 2022 (GLOBE NEWSWIRE) -- For Immediate Release: November 29, 2022 Townsend, TN — Company Distilling announces the newest offering in their premium spirits...
Morgan Wallen Foundation and Greater Good Music Provide Thanksgiving Dinners for 2,000 Families
21 nov. 2022 11h30 HE
|
Greater Good Music
NASHVILLE, Tenn., Nov. 21, 2022 (GLOBE NEWSWIRE) -- It's been a tough year to make ends meet with rising inflation and historically high food costs making it difficult for families to afford...
Provectus Biopharmaceuticals Announces Acceptance of Small Molecule Cancer Immunotherapy PV-10® Stage III Melanoma Abstract at Melanoma Bridge 2022
10 nov. 2022 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from the Company’s ongoing, multi-cohort, Phase 1b/2 study of the combination therapy of cancer...
Provectus Biopharmaceuticals Announces World Health Organization Selection of “Rose Bengal Sodium” as International Nonproprietary Name for Active Pharmaceutical Ingredient
02 nov. 2022 09h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the International Nonproprietary Names (INN) Expert Committee of the World Health Organization (WHO) has...